Day One Biopharmaceuticals Inc (DAWN)
Day One Appoints Michael Vasconcelles, M.D., as Headof Research and Development
Insulet Corporation (PODD)
Insulet - Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
Vivani Medical Inc. (VANI)
Vivani Medical to Present at the 2025 BIO International Convention
Oragenics Inc. (OGEN)
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
Gain Therapeutics Inc. (GANX)
Gain Therapeutics to Participate in Upcoming Investor Conferences
Outlook Therapeutics Inc. (OTLK)
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Novo Nordisk (NVO)
ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S
X4 Pharmaceuticals Inc. (XFOR)
X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA
Arcutis Biotherapeutics (ARQT)
Arcutis Enrolls First Child in INTEGUMENT-INFANT EvaluatingZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis